Vertex Pharmaceuticals Incorporated is a company in the U.S. stock market and it is a holding in 205 U.S.-traded ETFs. VRTX has around 24.9M shares in the U.S. ETF market. The largest ETF holder of VRTX is the Invesco QQQ Trust (QQQ), with approximately 2.99M shares. Investors may also find of interest that the ETF with the largest allocation to VRTX stock is iShares NASDAQ Biotechnology ETF (IBB), with a portfolio weight of 5.95%. On average, U.S. ETFs allocate 0.57% of VRTX to their portfolios.
Additionally, VRTX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VRTX as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 139.56%.